Towards Healthcare
U.S. Anti-Aging Market to Surge USD 39.6 Bn by 2034

U.S. Anti-Aging Market Surges with Skincare and Injectables

Market insights predict, the U.S. anti-aging industry is expected to grow from USD 20.21 billion in 2024 to USD 39.6 billion by 2034, driven by a CAGR of 6.95%. The U.S. anti-aging market is expanding due to growing demand for regenerative medicines as well as rising skincare awareness.

  • Last Updated: 01 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The U.S. anti-aging market is valued at USD 21.61 billion in 2025 and is on track to reach USD 39.6 billion by 2034, witnessing a steady CAGR of 6.95% during the forecast span.

The U.S. is currently leading the market share by 48% due to a growing aging population.

The U.S. anti-aging market includes five segments such as by product/treatment type, by channel/distribution, by age/demographic, by technology/science platform, and by end user/buyer type.

Some key players include Allergan Aesthetics, Galderma, Merz Aesthetics, and Revance Therapeutics.  

The different anti-aging products include topical skincare, cosmeceuticals, ingestible supplements, prescription dermatology, medical aesthetic injectables, energy-based aesthetic devices, and clinical regenerative approaches.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.